Alzamend Neuro is a clinical stage drug developer in Atlanta working on treatments for Alzheimer's and other brain disorders. It last closed at $0.78 on Nov 20, down 23.94% on the day. For the quarter ended Jul 2026, ALZN reported EPS of -$0.68. Over its last 3 reports the stock moved an average of 4.3% the session after earnings. Over the last 12 months ALZN insiders bought $109K of stock on the open market and sold $14K, according to SEC Form 4 filings.
AI Auto Pilots
Is ALZN in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ALZN.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on ALZNStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
ALZN · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 60% below its 20 day and 83% below its 50 day average. It is 81% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 22), oversold. The nearest support is the 52 week low at $0.75, and the nearest resistance the Pivot at $0.84.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 19.7%/day
Key levels
$2.5452 week high+225.6%
$1.4250 day average+82.1%
$1.42100 day average+82.1%
$1.41200 day average+80.8%
$1.2420 day average+59.0%
$1.24Swing high (May 29)+59.0%
$0.93Pivot R1+19.2%
$0.84Pivot+7.7%
$0.78Last close
$0.7552 week low−3.8%
$0.69Pivot S1−11.5%
Indicators
RSI (14)
22.50
Oversold below 30
Oversold
MACD
-0.10
Below its signal line
Bearish
Stochastic
3.4
Near the bottom of its range
Oversold
ADX (14)
26.3
Trending down
Williams %R
-97.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-209.4
Oversold below −100, overbought above 100
Oversold
Rate of change
−45.0%
Change over 10 sessions
Bearish
ATR (14)
$0.15
Typical daily range, 19.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 38.3%/day
Key levels
$2.5452 week high+225.6%
$1.4250 day average+82.1%
$1.42100 day average+82.1%
$1.41200 day average+80.8%
$1.2420 day average+59.0%
$1.24Swing high (May 29)+59.0%
$0.93Pivot R1+19.2%
$0.84Pivot+7.7%
$0.78Last close
$0.7552 week low−3.8%
$0.69Pivot S1−11.5%
Indicators
RSI (14)
33.21
Weak, oversold below 30
Neutral
MACD
-0.12
Below its signal line
Bearish
Stochastic
18.3
Near the bottom of its range
Oversold
ADX (14)
15.0
No clear trend
Williams %R
-98.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-170.6
Oversold below −100, overbought above 100
Oversold
Rate of change
−54.9%
Change over 10 sessions
Bearish
ATR (14)
$0.30
Typical daily range, 38.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for ALZN
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ALZN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow ALZN usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for ALZNHow many large options trades hit ALZN, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in ALZN in the last 90 days.
From SEC Form 4 filings by ALZN's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ALZN is in one of them and how their past ALZN trades turned out.
Alzamend Neuro is a clinical stage drug developer based in Atlanta, Georgia, focused on brain disorders. It is working on treatments for Alzheimer's disease, bipolar disorder, major depressive disorder and post traumatic stress disorder. Its lead candidate, AL001, is a form of lithium designed to treat these conditions, and it is in human clinical trials. Its target patients are people living with these illnesses.